Familial risk for lung cancer
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Lung cancer, which has a low survival rate, is a leading cause of cancer-associated mortality worldwide. Smoking and air pollution are the major causes of lung cancer; however, numerous studies have demonstrated that genetic factors also contribute to the development of lung cancer. A family history of lung cancer increases the risk for the disease in both smokers and never-smokers. This review focuses on familial lung cancer, in particular on the familial aggregation of lung cancer. The development of familial lung cancer involves shared environmental and genetic factors among family members. Familial lung cancer represents a good model for investigating the association between environmental and genetic factors, as well as for identifying susceptibility genes for lung cancer. In addition, studies on familial lung cancer may help to elucidate the etiology and mechanism of lung cancer, and may identify novel biomarkers for early detection and diagnosis, targeted therapy and improved prevention strategies. This review presents the aetiology and molecular biology of lung cancer and then systematically introduces and discusses several aspects of familial lung cancer, including the characteristics of familial lung cancer, population-based studies on familial lung cancer and the genetics of familial lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution
Pope III, C. A. (2002) · JAMA · doi:10.1001/jama.287.9.1132 · Cited by 8,447 · cited 3×
“In their study, the association between air pollution and lung cancer remained significantly high, even after controlling for factors such as cigarette smoking, body mass index, diet and occupational exposure (17).”
InfluentialIdentification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446 · cited 1×
“ALK-positive lung cancer patients are typically young, regardless of ethnicity, with minimal or no exposure to tobacco, and have adenocarcinoma (52).”
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Methodology for Genetic Studies of Twins and Families
Neale, M. C., & Cardon, L. R. (1992) · doi:10.1007/978-94-015-8018-2 · Cited by 4,005
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656 · cited 2×
“Johnson et al (65) were the first to identify a role for miRNA expression in the regulation of genes associated with lung cancer.”
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608 · cited 2×
“Acquired EGFR mutations are frequently identified among female non-smokers in East Asia, and indicate that they will be responsive to EGFR-targeted therapies (44).”
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Bergethon, K., Shaw, A. T., Ignatius Ou, S.-H., Katayama, R., Lovly, C. M., McDonald, N. T., Massion, P. P., Siwak-Tapp, C., Gonzalez, A., Fang, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6345 · Cited by 1,555
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320 · cited 2×
“…have been identified by ROS1‑solute carrier family 34 member 2 (SLC34A2) and ROS1-cluster of differentiation 74 (CD74) fusions, which involve the fusion of the 5' region of SLC34A2 with the 3' region of ROS1 and the fusion of the 5' region of CD74 with the 3' region of ROS1, respectively (55).”
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275 · cited 2×
“Genome-wide association studies independently revealed that the chromosomal region 15q24‑25.1 is associated with an increased risk for nicotine dependence and lung cancer development (95,96).”
InfluentialThe tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Lee, Y. S., & Dutta, A. (2007) · Genes & Development · doi:10.1101/gad.1540407 · Cited by 1,152 · cited 1×
“Members of the let-7 family can inhibit the expression of several oncogenes, including RAS, MYC and high mobility group AT-hook 2 (66).”
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063 · cited 1×
“In addition, high-level microsatellite instability has been observed in CRC patients (80).”
Indoor air pollution in developing countries and acute lower respiratory infections in children
Smith, K. R. (2000) · Thorax · doi:10.1136/thorax.55.6.518 · Cited by 947
Breast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
KIF5B-RET fusions in lung adenocarcinoma
Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799 · cited 1×
“B-RAF mutations are prevalent in females with lung adenocarcinoma, regardless of smoking history (47).”
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
Bethune, G. C., Bethune, D. C. G., Ridgway, N. D., & Xu, Z. (2010) · Europe PMC (PubMed Central) · Cited by 651
Familial adenomatous polyposis
Half, E., Bercovich, D., & Rozen, P. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-22 · Cited by 596
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578 · cited 1×
“K‑RAS mutations are more frequently observed in Western populations than in Asian populations, and in male smokers than in female smokers (37,38).”
The biology and treatment of EML4-ALK non-small cell lung cancer
Sasaki, T., Rodig, S. J., Chirieac, L. R., & Jänne, P. A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.002 · Cited by 555 · cited 1×
“Among these variants, E13:A20 (including exon 13 of EML4 and exon 20 of ALK) and E6a/b:A20 (variant 3a/b) are the most common, accounting for 33 and 29%, respectively, of all the EML4-ALK variants recognised in NSCLC (53).”
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Wang, R., Hu, H., Pan, Y., Li, Y., Ye, T., Li, C., Luo, X., Wang, L., Li, H., Zhang, Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1477 · Cited by 546
Bell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 531 · cited 1×
“In the study, the EGFR T790M variant resulted in a subtle alteration in EGFR signalling and enhanced the effect of other activating mutations in the same region (98).”
Wells, S. A., Gosnell, J. E., Gagel, R. F., Moley, J., Pfister, D., Sosa, J. A., Skinner, M., Krebs, A., Vasselli, J., & Schlumberger, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6604 · Cited by 519 · cited 1×
“Hereditary forms of medullary thyroid cancer develop because of inherited mutations in the RET oncogene; thus, these forms of cancer are sensitive to the RET tyrosine kinase inhibitor Vandetanib (74).”
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
Ladanyi, M., & Pao, W. (2008) · Modern Pathology · doi:10.1038/modpathol.3801018 · Cited by 364 · cited 1×
“Of the known EGFR tyrosine kinase domain mutations, >90% occur as point mutations or deletions in exon 19 (42,43).”
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360 · cited 1×
“K‑RAS mutations are more frequently observed in Western populations than in Asian populations, and in male smokers than in female smokers (37,38).”
RET Proto-Oncogene in the Development of Human Cancer
Eng, C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.380 · Cited by 339 · cited 1×
“RET fusions occurs in patients without other common oncogenes, such as EGFR, K-RAS and ALK (58,59).”
Genetic Influence on Smoking — A Study of Male Twins
Carmelli, D., Swan, G. E., Robinette, D., & Fabsitz, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209173271201 · Cited by 329 · cited 1×
“In addition, a low probability of lung cancer development was observed in a person whose identical twin was suffering from lung cancer (21).”
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25
Bailey-Wilson, J. E., Amos, C. I., Pinney, S. M., Petersen, G. M., de Andrade, M., Wiest, J. S., Fain, P., Schwartz, A. G., You, M., Franklin, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423857 · Cited by 316 · cited 2×
“The risk of lung cancer in individuals with a family history of cancer among first‑degree relatives is increased by ~50% compared with those without a family history, and this association is not affected by gender, ethnicity, histological types and other known lung cancer risk factors (23).”
Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
Weiss, G. J., Bemis, L. T., Nakajima, E., Sugita, M., Birks, D. K., Robinson, W. A., Varella-Garcia, M., Bunn, P. A., Haney, J., Helfrich, B. A., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn006 · Cited by 244 · cited 1×
“An inhibitor of miR-128b upregulated EGFR expression in an EGFR-expressing NSCLC cell line, and treatment with miR‑128b mimics significantly reduced EGFR expression (67).”
Cancer in Twins: Genetic and Nongenetic Familial Risk Factors
Ahlbom, A., Lichtenstein, P., Malmstrom, H., Feychting, M., Pedersen, N. L., & Hemminki, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.4.287 · Cited by 236
Spitz, M. R., Amos, C. I., Dong, Q., Lin, J., & Wu, X. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn363 · Cited by 229 · cited 1×
“Genome-wide association studies independently revealed that the chromosomal region 15q24‑25.1 is associated with an increased risk for nicotine dependence and lung cancer development (95,96).”
InfluentialOsada, H., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205802 · Cited by 223 · cited 1×
“Alterations in oncogenes and tumour suppressor genes have been shown to trigger cancer (35).”
Molecular Pathogenesis of Lung Cancer
Zöchbauer-Müller, S., Gazdar, A. F., & Minna, J. D. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155828 · Cited by 209
Coté, M. L., Liu, M., Bonassi, S., Neri, M., Schwartz, A. G., Christiani, D. C., Spitz, M. R., Muscat, J. E., Rennert, G., Aben, K. K., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.01.038 · Cited by 206 · cited 2×
“…and a large number of studies have indicated that individuals with a family history of lung cancer are two-to three-fold more susceptible to lung cancer development than those without such a history; this association is strongest for those whose siblings have been affected by lung cancer (22).”
Indoor air pollution and risk of lung cancer among Chinese female non-smokers
Mu, L., Liu, L., Niu, R., Zhao, B., Shi, J., Li, Y., Swanson, M., Scheider, W., Su, J., Chang, S.-C., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0130-8 · Cited by 192 · cited 2×
“Approximately, half of the world's population is at risk of developing respiratory diseases due to the use of unprocessed biomass fuel and coal for cooking and heating (10,11).”
Lung Cancer Incidence and Long-Term Exposure to Air Pollution from Traffic
Raaschou-Nielsen, O., Andersen, Z. J., Hvidberg, M., Jensen, S. S., Ketzel, M., Sørensen, M., Loft, S., Overvad, K., & Tjønneland, A. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002353 · Cited by 181 · cited 4×
“Outdoor air pollution, which is mainly caused by emissions from transportation, power generation, factories, industrial plants and agriculture, increases the risk of respiratory and cardiovascular diseases (10).”
InfluentialThe ras superfamily of small GTP-binding proteins
Downward, J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90300-z · Cited by 175 · cited 1×
“RAS genes were one of the first documented oncogenes and were named H-RAS (homologous to heavy murine sarcoma virus oncogene), K-RAS (homologous to Kirsten murine sarcoma virus oncogene) and N-RAS (initially isolated from neuroblastoma cell lines) (36).”
Osann, K. (1991) · PubMed · Cited by 163
BRCA mutations in the management of breast cancer: the state of the art
Narod, S. A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.166 · Cited by 161 · cited 1×
“BRCA1 and 2 genes have a central role in the DNA repair system via homologous recombination, and their absence increases cell sensitivity to particular DNA damaging agents (75,76).”
Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer
Liu, P., Vikis, H. G., Wang, D., Lu, Y., Wang, Y., Schwartz, A. G., Pinney, S. M., Yang, P., de Andrade, M., Petersen, G. M., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn268 · Cited by 154 · cited 2×
“Approximately 8% of lung cancers are inherited or occur as a result of a genetic predisposition (82,87).”
Barone-Adesi, F., Chapman, R. S., Silverman, D. T., He, X., Hu, W., Vermeulen, R., Ning, B., Fraumeni, J. F., Rothman, N., & Lan, Q. (2012) · BMJ · doi:10.1136/bmj.e5414 · Cited by 152 · cited 1×
“Another study reported that the mortality rate associated with lung cancer in Xuanwei, China was higher among users of smoky coal than among users of smokeless coal; this indicated that indoor air pollution caused by smoky coal is a major cause of lung cancer in this region (12).”
Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
Wistuba, I. I., Berry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., & Gazdar, A. F. (2000) · PubMed · Cited by 148
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
Tissot, C., Couraud, S., Tanguy, R., Bringuier, P., Girard, N., & Souquet, P.-J. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.11.006 · Cited by 145 · cited 1×
“The B-RAF-V600E variant, which is the most frequent mutant allele, has been used to match patients genetically to B-RAF inhibitor therapy (46).”
Shimamura, T., Ji, H., Minami, Y., Thomas, R. K., Lowell, A. M., Shah, K., Greulich, H., Glatt, K. A., Meyerson, M., Shapiro, G. I., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0971 · Cited by 134
p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel‐Pursiainen, K., Boffetta, P., Kannio, A., Nyberg, F., Pershagen, G., Mukeria, A., Constantinescu, V., Fortes, C., & Benhamou, S. (2000) · PubMed · Cited by 133
Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping
Oxnard, G. R., Miller, V. A., Robson, M. E., Azzoli, C. G., Pao, W., Ladanyi, M., & Arcila, M. E. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318250ed9d · Cited by 128 · cited 1×
“This mutation has been associated with familial lung adenocarcinoma (99).”
Familial Risk of Lung Carcinoma in the Icelandic Population
Jónsson, S. (2004) · JAMA · doi:10.1001/jama.292.24.2977 · Cited by 127 · cited 4×
“However, shared environmental factors could not be ignored, as a considerably increased RR was also observed in the spouses of lung cancer patients (87).”
InfluentialInamura, K., Ninomiya, H., Ishikawa, Y., & Matsubara, O. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-0586-rar1.1 · Cited by 122
Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
Yamamoto, H., Higasa, K., Sakaguchi, M., Shien, K., Soh, J., Ichimura, K., Furukawa, M., Hashida, S., Tsukuda, K., Takigawa, N., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt338 · Cited by 121 · cited 2×
“A novel germline point mutation HER2 G660D has been recently identified in never-smoker relatives with multi-generational lung adenocarcinoma (50).”
Bromen, K., Pohlabeln, H., Jahn, I., Ahrens, W., & Jöckel, K. H. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.6.497 · Cited by 113 · cited 2×
“Familial aggregation of lung cancer is frequently observed in clinical studies (81-84).”
Luk, C. K., Tsao, M., Bayani, J., Shepherd, F. A., & Squire, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00363-0 · Cited by 112 · cited 1×
“Gains involving chromosome 5p are another frequent abnormality observed in NSCLC. Karyotype studies identified polysomy in most parts of chromosome 7 (29-31).”
Targeting HER2 in the treatment of non-small cell lung cancer
Mar, N., Vredenburgh, J. J., & Wasser, J. S. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2014.12.018 · Cited by 110 · cited 1×
“HER2 mutations have been identified in 2‑4% of NSCLC cases, and the majority of mutations involved insertions at exon 20 (48).”
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer
Lin, L., Asthana, S., Chan, E., Bandyopadhyay, S., Martins, M. M., Olivas, V., Yan, J. J., Pham, L., Wang, M. M., Bollag, G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320956111 · Cited by 105 · cited 1×
“Oncogenic mutations in B-RAF occur in 6-8% of NSCLC cases, accounting for >90,000 deaths per year worldwide (45).”
Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer
Yu, X., Yang, M., Zhou, B., Wang, G., Huang, Y., Wu, L., Cheng, X., Wen, Z., Huang, J.-Y., Zhang, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.04.003 · Cited by 105 · cited 1×
“Whole‑genome sequencing and exome sequencing can be used to identify genes that cause diseases, not only in probands but also in the successive generations (94).”
Self-citationRisk of Lung Cancer Among White and Black Relatives of Individuals With Early-Onset Lung Cancer
Coté, M. L. (2005) · JAMA · doi:10.1001/jama.293.24.3036 · Cited by 101
Mortality from lung cancer in workers exposed to sulfur dioxide in the pulp and paper industry.
Lee, W. J., Teschke, K., Kauppinen, T. P., Andersen, A., Jäppinen, P., Szadkowska‐Stańczyk, I., Pearce, N. E., Persson, B., Bergeret, A., Facchini, L. A., et al. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110991 · Cited by 97 · cited 1×
“Other studies suggested that sulphur dioxide exposure in the paper and pulp industry contributes to lung carcinogenesis (15,16).”
Association Between Lung Cancer Incidence and Family History of Lung Cancer
Nitadori, J., Inoue, M., Iwasaki, M., Otani, T., Sasazuki, S., Nagai, K., & Tsugane, S. (2006) · CHEST Journal · doi:10.1378/chest.130.4.968 · Cited by 96
Tammemägi, M. C., McLaughlin, J. R., & Bull, S. B. (1999) · PubMed · Cited by 96
Cytogenetics and molecular genetics of lung cancer
Mitsuuchi, Y., & Testa, J. R. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10692 · Cited by 91 · cited 3×
“Numerous chromosomal abnormalities have been documented in lung cancer; these abnormalities include allelic loss, isochromo-somes, unbalanced translocation and loss of heterozygosity (LOH) (24).”
ROS1 fusions in Chinese patients with non-small-cell lung cancer
Cai, W., Li, X., Su, C., Fan, L., Zheng, L.-M., Fei, K., Zhou, C., Manegold, C., & Schmid‐Bindert, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt071 · Cited by 90 · cited 1×
“ROS1 fusions are widespread in never-smokers with a histological diagnosis of adenocarcinoma (54).”
You, M., Wang, D., Liu, P., Vikis, H. G., James, M. A., Lü, Y., Wang, Y., Wang, M., Chen, Q., Jia, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2335 · Cited by 90 · cited 1×
“A functional study indicated that RGS17 is highly expressed in tumour tissues and that its overexpression increases the proliferation rate of tumour cells (97).”
Management strategies for patients with hereditary pancreatic cancer
Brentnall, T. A. (2005) · Current Treatment Options in Oncology · doi:10.1007/s11864-005-0046-6 · Cited by 85 · cited 5×
“Familial cancer is characterised by gene mutations in two or more first‑degree relatives diagnosed with the same type of cancer; this condition is influenced by a hereditary predisposition, variable gene penetrance and environmental factors (1).”
InfluentialTesta, J. R., Siegfried, J. M., Liu, Z., Hunt, J. D., Feder, M., Litwin, S., Zhou, J., Taguchi, T., & Keller, S. M. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110307 · Cited by 85 · cited 1×
“Gains involving chromosome 5p are another frequent abnormality observed in NSCLC. Karyotype studies identified polysomy in most parts of chromosome 7 (29-31).”
Inherited predisposition to early onset lung cancer according to histological type
Li, X., & Hemminki, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20436 · Cited by 74 · cited 2×
“For example, intensive surveillance programmes ensure an early diagnosis, and preventive surgery may reduce cancer-associated mortality (1,72).”
Genetic component of lung cancer: cohort study of twins
Braun, M. M., Caporaso, N. E., Hoover, R. N., & Page, W. F. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91770-1 · Cited by 73 · cited 2×
“Another study suggested that genetic factors do not exhibit strong prognostic value for lung cancer risk in twins (18).”
Dose effect of smoking on aberrant methylation in non‐small cell lung cancers
Toyooka, S., Suzuki, M., Tsuda, T., Toyooka, K. O., Maruyama, R., Tsukuda, K., Fukuyama, Y., Iizasa, T., Fujisawa, T., Shimizu, N., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20125 · Cited by 70
Chambers, A., Routledge, T., Pilling, J. E., & Scarci, M. (2010) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.233189 · Cited by 66 · cited 1×
“Early-stage lung cancer can be treated surgically with a good survival rate; however, most cases are identified in the late stages when surgery is no longer an option as a result of distant metastases (3).”
Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors
Joosse, S. A., Brandwijk, K. I. M., Mulder, L., Wesseling, J., Hannemann, J., & Nederlof, P. M. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20833 · Cited by 59 · cited 4×
“Studies on familial cancers have revealed various important oncogenes and tumour suppressor genes, including BRCA1, BRCA2, Rb and VHL (77,78).”
InfluentialDrug therapy for hereditary cancers
Имянитов, Е. Н., & Moiseyenko, V. M. (2011) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-9-5 · Cited by 51 · cited 3×
“Approximately 1-5% of human cancers develop because of known germline defects (69,71).”
Gaughan, E. M., Cryer, S. K., Yeap, B. Y., Jackman, D. M., & Costa, D. B. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.002 · Cited by 49
Thompson, E. R., Rowley, S. M., Sawyer, S. D., kConFab, Eccles, D., Trainer, A. H., Mitchell, G., James, P. A., & Campbell, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054772 · Cited by 42 · cited 1×
“Breast, colon, bladder and ovarian cancers are commonly associated with an hereditary predisposition (69,70).”
RET Fusion Genes in Non–Small-Cell Lung Cancer
Chao, B. H., Briesewitz, R., & Villalona-Calero, M. A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8240 · Cited by 41
Schenk, T., Ackermann, J., Brunner, C., Schenk, P., Zojer, N., Roka, R., & Drach, J. W. (1997) · CHEST Journal · doi:10.1378/chest.111.6.1691 · Cited by 37 · cited 1×
“Extensive aneusomy (gain of 2 or more chromosomes per cell) is the most commonly observed chromosomal change in patients with NSCLC (25,26).”
Ohyama, K.-I., Ito, T., & Kanisawa, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00040-3 · Cited by 25 · cited 2×
“Sulphur dioxide, a major air pollutant and co-carcinogen, increases respiratory disease-associated mortality (14).”
Familial colorectal cancer: Patient assessment, surveillance and surgical management
Kennelly, R. P., Gryfe, R., & Winter, D. C. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.07.008 · Cited by 15 · cited 1×
“CRC is triggered by defects in the DNA repair system, usually germline mutations in the Mut L homolog 1, Mut S homolog 2, postmeiotic segregation increased 2 and Mut S homolog 6 genes (78,79).”
Systemic treatment for hereditary cancers: a 2012 update
Имянитов, Е. Н., & Byrski, T. (2013) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-11-2 · Cited by 8 · cited 1×
“BRCA1 and 2 genes have a central role in the DNA repair system via homologous recombination, and their absence increases cell sensitivity to particular DNA damaging agents (75,76).”
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90516-z · Cited by 2 · cited 2×
“TP53 mutations have been associated with exposure to environmental tobacco smoke and a smoking history (61).”
Cited by
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Chaitanya Thandra, K., Barsouk, A., Saginala, K., Sukumar Aluru, J., & Barsouk, A. (2021) · Współczesna Onkologia · doi:10.5114/wo.2021.103829 · Cited by 890
Radon Biomonitoring and microRNA in Lung Cancer
Bersimbaev, R., Pulliero, A., Bulgakova, O., Kussainova, A., Aripova, A., & Izzotti, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062154 · Cited by 53
Oxidative stress in lung cancer
Mousapasandi, A., Loke, W. S. J., Herbert, C. A., & Thomas, P. S. (2021) · Cancer · doi:10.1016/b978-0-12-819547-5.00003-1 · Cited by 5
Metadata
- Authors
- Kanwal, M., Ding, X.-J., & Cao, Y.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2016-12-20
- Volume
- 13
- Issue
- 2
- Pages
- 535-542
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2564667896
- Cited by
- 206
- References
- 81
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.